Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,238.80
(
0.09%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
92.81
(
-4.30%
)
Bitcoin
74,885.15
(
-1.27%
)
News Focus
News Focus
Post# of 827875
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

meirluc

Send PM Follow Ignore
Followers 57
Posts 3177
Boards Moderated 0
Alias Born 02/01/2017

meirluc

Re: flipper44 post# 659041

Monday, 12/25/2023 1:13:25 PM

Monday, December 25, 2023 1:13:25 PM

Post# of 827875
Thank you Flipper and DD for your answers. If we obtain
enough evidence of CSF-1R's utility in the combo and/or
that keytruda is a plus, than Merck is the BP with the
partnership/BO advantage. Otherwise I am looking forward
to a fierce BP competition for NWBO's favors and that is also
not a bad alternative.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News